4.8 Article

Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

Ethnic and sex differences in hepatic lipid content and related cardiometabolic parameters in lean individuals

Kitt Falk Petersen et al.

Summary: The study found that the 95th percentile of hepatic triglyceride (HTG) in lean non-Al individuals was 1.85% and HTG concentrations above this threshold were associated with insulin resistance (IR) and cardiovascular risk factors. Premenopausal women were protected from these changes whereas young, lean Asian Indian (AI) men and women manifested increased HTG content and associated cardiometabolic risk factors.

JCI INSIGHT (2022)

Article Gastroenterology & Hepatology

Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease

Panu K. Luukkonen et al.

Summary: This study demonstrated that the mechanisms underlying the metabolic and genetic components of NAFLD are fundamentally different. The metabolic component is characterized by hepatic oversupply of substrates, while the genetic component is characterized by impaired hepatic mitochondrial function.

JOURNAL OF HEPATOLOGY (2022)

Article Pharmacology & Pharmacy

Therapeutic effect of uridine phosphorylase 1 (UPP1) inhibitor on liver fibrosis in vitro and in vivo

Elisa Feller Goncalves da Silva et al.

Summary: CPBMF65, as a potent inhibitor of the UPP1 enzyme, has shown potential therapeutic effects on adverse effects of chemotherapy, lung injury, and liver fibrosis. In vitro, CPBMF65 decreased cell proliferation and induced phenotype reversion. In a mouse model of liver fibrosis, CPBMF65 exhibited anti-fibrotic and anti-inflammatory actions.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Rohit Loomba et al.

Summary: NAFLD and NASH are leading chronic liver diseases worldwide, causing progressive liver injury that can lead to cirrhosis and hepatocellular carcinoma. These diseases are associated with hepatic glucose and lipid metabolism, and are influenced by genetic, epigenetic, and environmental factors.
Article Multidisciplinary Sciences

Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease

Panu K. Luukkonen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Gastroenterology & Hepatology

Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort

Quentin M. Anstee et al.

JOURNAL OF HEPATOLOGY (2020)

Review Endocrinology & Metabolism

Through the Looking-Glass: Reevaluating DHEA Metabolism Through HSD3B1 Genetics

Bryan D. Naelitz et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)

Article Cell Biology

Physiological and Molecular Dissection of Daily Variance in Exercise Capacity

Saar Ezagouri et al.

CELL METABOLISM (2019)

Article Gastroenterology & Hepatology

Past, present and future perspectives in nonalcoholic fatty liver disease

Arun J. Sanyal

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source

Michelle L. Boland et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Article Medicine, General & Internal

A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease

N. S. Abul-Husn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Biochemistry & Molecular Biology

RNA-Seq reveals common and unique PXR- and CAR-target gene signatures in the mouse liver transcriptome

Julia Yue Cui et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)

Review Cell Biology

Phospholipid Synthesis and Transport in Mammalian Cells

Jean E. Vance

TRAFFIC (2015)

Review Medicine, General & Internal

Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease

Gerald I. Shulman

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Pharmacology & Pharmacy

Uridine prevents tamoxifen-induced liver lipid droplet accumulation

Thuc T. Le et al.

BMC PHARMACOLOGY & TOXICOLOGY (2014)

Article Pathology

An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis

Masahiko Matsumoto et al.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2013)

Article Biochemistry & Molecular Biology

Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation

Thuc T. Le et al.

JOURNAL OF LIPID RESEARCH (2013)

Article Biochemical Research Methods

Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA

Atanas Kamburov et al.

BIOINFORMATICS (2011)

Article Gastroenterology & Hepatology

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

DE Kleiner et al.

HEPATOLOGY (2005)